Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhishen Ye

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Journal of Biopharmaceutical Statistics|February 21, 2018
Controlling alpha for mixed effects models for repeated measuresZhishen Ye, B Nebiyou Bekele
Statistics in Medicine|August 7, 2024
Exact test and exact confidence interval for the Cox modelYongwu Shao, Zhishen Ye, Zhiwei Zhang
Pharmaceutical Statistics|April 8, 2024
Information-based group sequential design for post-market safety monitoring of medical products using real world dataZhiwei Zhang, Carrie Nielson, Ching-Yi Chuo, et al.
Journal of Clinical Epidemiology|March 17, 2004
Linking hospital discharge and death records--accuracy and sources of biasDavid S Zingmond, Zhishen Ye, Susan L Ettner, et al.
IEEE Transactions on Pattern Analysis and Machine Intelligence|April 28, 2026
Causality-Preserving Domain Generalization via Adaptive Fourier Mixup for RUL PredictionYifan Zhu, Wenyu Chen, Zhe Cheng, et al.
Clinical Lung Cancer|December 16, 2005
Gemcitabine/carboplatin in patients with metastatic non-small-cell lung cancer: phase II study of 28-day and 21-day schedulesColeman K Obasaju, Zhishen Ye, Leslie P Bloss, et al.
Plos One|July 30, 2019
Genomic modeling of hepatitis B virus integration frequency in the human genomeOndrej Podlaha, George Wu, Bryan Downie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2003
Knowledge of antiretroviral regimen dosing and adherence: a longitudinal studyLoren G Miller, Honghu Liu, Ron D Hays, et al.
Lung Cancer (Amsterdam, Netherlands)|May 30, 2006
Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: a phase II trialJoseph Treat, Philip Bonomi, Michael McCleod, et al.
Clinical Breast Cancer|July 9, 2005
Phase II study of pemetrexed in patients pretreated with an anthracycline, a taxane, and capecitabine for advanced breast cancerJoyce A O'Shaughnessy, Romnee S Clark, Joanne L Blum, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of Biopharmaceutical Statistics|February 21, 2018
Controlling alpha for mixed effects models for repeated measuresZhishen Ye, B Nebiyou Bekele
Statistics in Medicine|August 7, 2024
Exact test and exact confidence interval for the Cox modelYongwu Shao, Zhishen Ye, Zhiwei Zhang
Pharmaceutical Statistics|April 8, 2024
Information-based group sequential design for post-market safety monitoring of medical products using real world dataZhiwei Zhang, Carrie Nielson, Ching-Yi Chuo, et al.
Journal of Clinical Epidemiology|March 17, 2004
Linking hospital discharge and death records--accuracy and sources of biasDavid S Zingmond, Zhishen Ye, Susan L Ettner, et al.
IEEE Transactions on Pattern Analysis and Machine Intelligence|April 28, 2026
Causality-Preserving Domain Generalization via Adaptive Fourier Mixup for RUL PredictionYifan Zhu, Wenyu Chen, Zhe Cheng, et al.
Clinical Lung Cancer|December 16, 2005
Gemcitabine/carboplatin in patients with metastatic non-small-cell lung cancer: phase II study of 28-day and 21-day schedulesColeman K Obasaju, Zhishen Ye, Leslie P Bloss, et al.
Plos One|July 30, 2019
Genomic modeling of hepatitis B virus integration frequency in the human genomeOndrej Podlaha, George Wu, Bryan Downie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2003
Knowledge of antiretroviral regimen dosing and adherence: a longitudinal studyLoren G Miller, Honghu Liu, Ron D Hays, et al.
Lung Cancer (Amsterdam, Netherlands)|May 30, 2006
Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: a phase II trialJoseph Treat, Philip Bonomi, Michael McCleod, et al.
Clinical Breast Cancer|July 9, 2005
Phase II study of pemetrexed in patients pretreated with an anthracycline, a taxane, and capecitabine for advanced breast cancerJoyce A O'Shaughnessy, Romnee S Clark, Joanne L Blum, et al.
Pageof 3